Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | NPEPPS | P55786 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | GRIA1 | P42261 | 2/20 | 0.36 |
| ▸ | CACNG8 | Q8WXS5 | 2/20 | 0.36 |
| ▸ | FEN1 | P39748 | 1/20 | 0.36 |
| ▸ | PTGES | O14684 | 3/20 | 0.35 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.35 |
| ▸ | CDK1 | P06493 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27192346 | 0.92 | KDM4E (0.46) | TP53KDM4EHTTNPEPPSGAA | |
| SCHEMBL27191798 | 0.90 | KDM4E (0.43) | TP53KDM4EHTTNPEPPSGAA | |
| SCHEMBL29326444 | 0.90 | TP53 (0.44) | TP53KDM4EHTTNPEPPSGAA | |
| SCHEMBL27378570 | 0.90 | NPEPPS (0.39) | TP53KDM4EHTTNPEPPSGAA | |
| SCHEMBL27378574 | 0.88 | KDM4E (0.41) | TP53KDM4EHTTNPEPPSGAA | |
| SCHEMBL27191759 | 0.87 | PTGES (0.46) | TP53KDM4EHTTNPEPPSGAA | |
| SCHEMBL27192074 | 0.87 | KDM4E (0.42) | TP53KDM4EHTTNPEPPSGAA | |
| SCHEMBL30701987 | 0.85 | KDM4E (0.41) | TP53KDM4EHTTNPEPPSGAA | |
| SCHEMBL27191924 | 0.85 | KDM4E (0.41) | TP53KDM4EHTTNPEPPSGAA | |
| SCHEMBL27191898 | 0.85 | KDM4E (0.41) | TP53KDM4EHTTNPEPPSGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024031089-A1 | SARS-COV2 MAIN PROTEASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2024-02-08 | — | — | WO | disclosed |